HSF2 and cancer: The results implied that HSF2 expression was markedly correlated with the infiltrating level of B cells in 16 types of cancer, CD4+ T cells in 12 types of cancer, CD8+ T cells in 16 types of cancer, macrophages in 17 types of cancer, neutrophils in 18 types of cancer, and DCs in 18 types of cancer (Figure 8A).